Beta Bionics, Inc. (BBNX) Operating Margin (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Operating Margin data on file, last reported at 87.86% in Q1 2026.

• Quarterly Operating Margin rose 1783.0% year-over-year to 87.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 70.13% (up 783.0% YoY) and the FY2025 annual result came in at 71.5%, down 202.0% from the prior year.
• Operating Margin retreated to 87.86% in Q1 2026 per BBNX's latest filing, from 50.2% in the prior quarter.
• The five-year high for Operating Margin was 50.2% in Q4 2025, with the low at 105.69% in Q1 2025.
• Average Operating Margin over 3 years is 74.74%, with a median of 73.09% recorded in 2024.
• Year-over-year, Operating Margin plunged 3259 bps in 2025 and soared 1783 bps in 2026.
• Beta Bionics' Operating Margin stood at 63.78% in 2024, then rose by 21 bps to 50.2% in 2025, then plunged by 75 bps to 87.86% in 2026.
• Business Quant data shows BBNX's Operating Margin at 87.86% in Q1 2026, 50.2% in Q4 2025, and 62.54% in Q3 2025.